Standard operating procedure



Similar documents
Standard operating procedure

Standard operating procedure

Standard operating procedure

Standard operating procedure

Standard operating procedure

Standard operating procedure

Standard operating procedure

All the steps detailed in this WIN are carried out by the assistant in the Sampling and Testing Team in the MQC Section.

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions. Title: How to create reports from scientific memory database (SMD)

Opinion/ Commission. Notification. Decision. Issued 2 / affected 3 amended on. 30/07/2015 Annex II, Labelling and PL

End of consultation (deadline for comments) 14 October Adoption by Committee for advanced therapies 15 October 2010

EU Clinical Trials Register. An agency of the European Union

Quick Response (QR) codes in the labelling and package leaflet of centrally authorised 1 medicinal products

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control.

Questions & answers on signal management

Trial Delivery SOP 05 Trial Archiving

Compilation of Community Procedures on Inspections and Exchange of Information

EudraVigilance stakeholder change management plan

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials

Questions and answers relating to Open Procedure EMA ED Online Strategy and Interface Design

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Opinion/ Commission. Notification 1. Decision. Information issued on. Issued 2 / affected 3 amended on

Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

SP007 - Procedure for the Control of Documents & Data

Implementation strategy for ISO IDMP in EU

The EU portal and database

Video surveillance policy (PUBLIC)

Guidance for the format and content of the protocol of non-interventional post-authorisation safety studies

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

Compilation of individual product-specific guidance on demonstration of bioequivalence

Energy Management. System Short Guides. A Supplement to the EPA. Guidebook for Drinking Water and Wastewater Utilities (2008)

EMA esignature capabilities: frequently asked questions relating to practical and technical aspects of the implementation

Draft agreed by the QWP February Draft adopted by the CHMP for release for consultation March Draft endorsed by the CMD(h) March 2015

Archiving. Paper Documents

European Medicines Agency decision

Standard Operating Procedure for Archiving Essential Documentation relating to Clinical Trials of Investigational Medicinal Products (CTIMPs)

ICH guideline Q10 on pharmaceutical quality system

Reflection paper on non-spontaneous adverse event reports (peer-reviewed literature, internet and social media)

TOWN OF COTTESLOE POLICY MANAGEMENT

Questions and answers on post approval change management protocols

HSE P0801 HSE Document Control and Records Management Procedure

IMPORTANT DOCUMENT INVITATION TO NEGOTIATE REVISION. OPENING DATE & TIME: February 11, 2:00 PM ADDENDUM NUMBER: 2 ADDENDUM DATE: 1/17/2014

Project Management Fact Sheet:

Strategy and pilot phase for patient registries

Data submission of authorised medicines in the European Union

Frequently Asked Questions - Trainees at the EMA

The Clinical Trials Regulation EU No 536/2014: and Phase I trials

RECORD MANAGEMENT STANDARD OPERATING PROCEDURE (SOP)

GroupWise to Outlook Migration FAQ s

Work plan for GMP/GDP Inspectors Working Group for 2016

Life Cycle of Records

II. AREA OF INVOLVEMENT OF PATIENTS AND CONSUMERS IN EMEA ACTIVITIES

Draft agreed by the QWP February Draft adopted by the CHMP for release for consultation March Draft endorsed by the CMD(h) March 2015

Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials

Annex VI Service Level Agreement for Medical Service Provider

QUALITY MANAGEMENT SYSTEM DEVELOPMENT AND REVIEW PROCEDURE

Frequent Asked Questions related to tender EU-OSHA/CPU/2013/T3

Archiving of Clinical Trial Data and Essential Documentation JCTO/CT/SOP 4.0. Joint Clinical Trials Office. Stuart Hatcher, JCTO Archivist

Technical specifications for open invitation to tender

This SOP may also be used by staff from other NHS areas, or organisations, with prior agreement.

This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.

Clinical RiO Health Records Policy

Standard Operating Procedure

Archiving Study Documents

Working Instruction Template. Instructions for Archiving of Essential Trial Documents at Datatron Off Site Facility

Information Management Policy for The Treasury Department

To outline the process for creating and maintaining health and safety documentation for the JCU Health, Safety Management System (HSMS).

Student Records Management Review Issued by Caroline Dominey, Records Manager August 2012

30 Churchill Place: Orientation guide for staff EMA/151278/2015 Page 1/11

The Online Archive offers compared to the conventional PST files many advantages, e. g.:

HERON (No: ): Deliverable D.2.6 DATA MANAGEMENT PLAN AUGUST Partners: Oxford Brookes University and Università Commerciale Luigi Bocconi

Information Management Advice 27 Managing

Document Control Procedure

STANDARD OPERATING PROCEDURE LABORATORY LOGBOOKS

Wales Patient Access Scheme: Process Guidance

Document Management Plan Preparation Guidelines

Preservation and Production of Electronic Records

A records survey is a systematic exercise to locate and identify all the records held by a particular business area.

Policy Document Control Page

Staff information. management policy

The E-Discovery Process

MANAGING SHARED AREAS: FILE STRUCTURES

Schedule A RFP Data Sheet

Standard Operating Procedures

Workflow Notifications

RECORD KEEPING IN HEALTHCARE RECORDS POLICY

Chapter Quarterly Financial Report Instructions (Quarterly Format)

Administrative forms (Part A) Project proposal (Part B)

WHS DOCUMENT CONTROL GUIDELINES

The European regulatory system for medicines and the European Medicines Agency

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions EXPLANATORY NOTES

List of nationally authorised medicinal products

DOCUMENT AND RECORDS CONTROL PROCEDURE

UNIVERSITY OF LONDON RECORDS MANAGEMENT MANUAL: BEST PRACTICE PROCEDURE No. 4 ELECTRONIC RECORDS MANAGEMENT

Demographics QUESTIONS COMMENTS

Services Policy

Data Document Location Project information sheet (i) Word file on University shared drive (ii) on project web pages on University website

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders

XML Conversion Utility User Awareness

State of Michigan Records Management Services. Frequently Asked Questions About E mail Retention

Transcription:

Standard operating procedure Title: Evaluation procedure for eligibility of patients', consumers' and healthcare professionals organisations Status: Public Document no.: SOP/H/3390 Lead author Approver Effective date: 13-MAR-15 Name: Nathalie Bere Name: Isabelle Moulon Review date: 13-MAR-18 Signature: On file Signature: On file Supersedes: SOP/H/3390 (01-FEB-13) Date: Date: TrackWise record no.: 4320 1. Purpose The purpose of this SOP is to ensure a consistent and efficient approach in the evaluation procedure for eligibility of patients', consumers' and healthcare professionals organisations applying to be involved in the activities of the Agency. 2. Scope This SOP applies to the Patients & Healthcare Professionals Department in the Stakeholders & Communication Division. 3. Responsibilities It is the responsibility of each Head of Department to ensure that this procedure is adhered to within their own Department. The responsibility for the execution of a particular part of this procedure is identified in the right-hand column of section 9. 4. Changes since last revision Update of terminology following the new EMA organisational structure. Step 11 deleted for simplification. Minor editorial updates. 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged.

5. Documents needed for this SOP Application/re-evaluation form for the involvement of patients, consumers and healthcare professionals in the activities of the European Medicines Agency (EMA/520442/2010) - available on the EMA external website: Partners & networks/patients and consumers/getting involved/how to apply. Excel spreadsheet: Overview of evaluation_re-evaluation of PCOs (EMA/217271/2006) which is available in DREAM under: Cabinets/09. Relationship management and communication/09.1 Stakeholder liaison/06 Joint interaction PCOs & HCPs/Tracking & monitoring/tracking Tables. Excel spreadsheet: Overview of evaluation_re-evaluation of HCPOs (EMA/670841/2012) which is available in DREAM under: Cabinets/09. Relationship management and communication/09.1 Stakeholder liaison/06 Joint interaction PCOs & HCPs/Tracking & monitoring/tracking Tables. Templates: Acknowledgement of receipt of application email. Evaluation clarification letter. Letter advising removal from our webiste as documents not received named Removal of organisation from website. Evaluation(re-evaluation) sheet. Evaluation positive outcome letter. Evaluation negative outcome letter. Request email for documentation from new organisation. (note: all the above-mentioned templates are kept on the X Drive under: X Drive/Templates/Others/ Committees and WPs/H/PCO-HCP templates/pco-hcp evaluation and re-evaluation templates. Please note the following: The DREAM folder of each PCO is located under Cabinets/09. Relationship management and communication/09.1 Stakeholder liaison/05 Interactions with PCOs/Patient-consumer organisations/eligible organisations. The DREAM folder of each HCPO is located under: : Cabinets/09. Relationship management and communication/09.1 Stakeholder liaison/04 Interactions with HCPOs/HCP organisations/eligible organisations. Paper copies with wet signature are filed in ring binders kept in the Department called Organisations and are filed alphabetically by the name of the organisation. The EMA webpage listing the eligible PCO(s) is located here: Partners & networks/patients and consumers/organisations involved. The EMA webpage listing the eligible HCPO(s) is located here: Partners & networks/healthcare professionals/organisations involved. 6. Related documents Criteria to be fulfilled by patients and consumers organisations involved in European Medicines Agency (EMA/24913/2005 rev 2) - available on the EMA external website: Partners & networks/patients and consumers/getting involved. SOP/H/3390, 13-MAR-15 Page 2/7

Criteria to be fulfilled by healthcare professionals organisations involved in European Medicines Agency (EMA/161137/2011 rev 1) - available on the EMA external website: Partners & networks/ Healthcare Professionals/Getting involved. Evaluation of financial information from patients, consumers and healthcare professionals organisations for assessment of EMA eligibility (EMA/566453/2012) - available on the EMA external website: Partners & networks/patients and consumers/key documents. DREAM user manual available from IT service desk. 7. Definitions In this procedure the following abbreviations are used: AD AF-LD DREAM EvalCom EMA HCPO(s) Hdep PCO(s) S-PH Administrator (in S-PH) Assistant (in S-PH) Legal Department Document Records Electronic Archive Management Evaluation committee (composed of AF-LD representative, AD, and Hdep) European Medicines Agency Healthcare professional organisation(s) Head of Department (of S-PH) Patient and consumer organisation(s) Patients & Healthcare Professionals Department SOP/H/3390, 13-MAR-15 Page 3/7

8. Process map(s)/ flow chart(s) SOP/H/3390, 13-MAR-15 Page 4/7

9. Procedure Please note that active time excludes time taken by the organisation in responding to the EMA requests (eg. for clarification/additional information). Step Action Responsibility Initial evaluation of new application 1 Day 0 Receive application submitted by email to the PCWPSecretariat@ema.europa.eu or HCPsecretariat@ema.europa.eu inboxes or by post to the European Medicines Agency s address. 2 By day +5 Create a new folder in DREAM using the organisations acronym and save all documents received in this folder (scan hard copies). Create evaluation sheet from template and enter organisation details. 3 Send email acknowledging receipt to organisation s contact person and save electronic copy in relevant folder. 4 Check application for completeness of documentation (i.e. that everything requested in the application form has been submitted). Confirm with AD. Is information missing/clarification needed? Yes: go to step 4.1 No: go to step 5. 4.1 Request missing/additional information from organisation to be provided within 1 month. Note: if this is the second request advise that if information/clarification is not received within a further month, the procedure will be closed. 4.2 Reveived missing/additional information within 1 month? Yes: go to step 3. No: go to step 4.1 5 By day +6 Send outlook meeting request to EvalCom, to take place within 21 days of receipt of complete application. 6 Add the organisation s name on the excel spreadsheet Overview of evaluation_re-evaluation of PCOs/ HCPOs. 7 By day +14 Review application content according to eligibility criteria and fill in evaluation sheet accordingly. Confirm with AD. Is clarification needed? Yes: go to step 7.1. No: go to step 8. 7.1 Request additional clarification from the organisation to be provided within 1 month. Note: if this is the second request advise that if clarification is not received within a further month, the procedure will be closed. /AD /AD SOP/H/3390, 13-MAR-15 Page 5/7

Step Action Responsibility 7.2 Received additional clarification within 1 month? /AD Confirm with AD. Yes: go to step 7. No: go to step 7.1. 8 By day +15 Email all documents to EvalCom ahead of the evaluation meeting and prepare hard copies for the meeting (include application form, evaluation sheet and all supporting documentation received). 9 By day +21 EvalCom Conduct meeting and evaluate application. EvalCom to sign evaluation sheet according to outcome: Positive/negative outcome: go to step 10. Pending clarification: go to step 9.1. 9.1 Request additional information/clarification to be sent within 1 month. Note: if this is the second request advise that if clarification is not received within a further month, the procedure will be closed. 9.2 Received additional information/clarification within 1 month? Yes: go to step 9.3. No: go to step 9.1. 9.3 Evaluate information received and circulate to EvalCom by email AD/ for review. 9.4 EvalCom to confirm positive/negative outcome by email and sign EvalCom evaluation sheet accordingly. (A meeting may be requested to make final decision) 10 Prepare positive/negative outcome letter for signature by Hdep. 11 By day +30 Post signed letter to organisation and inform them by email. Keep electronic copy in relevant folder. 12 Update excel spreadsheet Overview of evaluation_re-evaluation of PCOs/HCPOs with the outcome and date of evaluation. End of procedure for negative outcome. 13 Include the new organisation on the EMA webpage dedicated to the relevant eligible organisation. Send an email to the webteam with the following information: name of organisation; acronym of organisation (if applicable); website address; summary of the organisations s activities (to be obtained from Mission/Objectives on the application form. 10. Records When the process of evaluation is completed, the application form and supporting documentation; scanned copies of the signed letters sent to the organisation are kept in the appropriately labelled folder in DREAM and are identified as a record by the S-PH assistant (retention time 5 years). SOP/H/3390, 13-MAR-15 Page 6/7

Evaluation committee outcome evaluation sheet having wet signature should be kept in a ring binder folder in the Department. SOP/H/3390, 13-MAR-15 Page 7/7